That is what most media reports missedeven though its the very first sentence of the paper
For semaglutide alone, trials relating to cardiovascular disease (SELECT), kidney disease (FLOW) and heart failure (STEP) have announced positive results in the last 12 months
In 2014, the FDA said it did not appear that sitagliptin drugs cause pancreatitis or pancreatic cancer, but that it had not reached a final conclusion
Underlying Health Conditions Certain medical conditions, such as hypothyroidism or hormonal imbalances, can impact weight loss efforts
But when the first GLP-1 pill for obesity became available in early January, Zuckerman called her doctor immediately, she said
Its an important presentation to be aware of, and with an overall mortality of around 10% (which has remained static for 50 years despite advances in medical management), early recognition and treatment can really make a big difference 1